• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Our Medications

  • AIRSUPRA<sup>®</sup> (albuterol and budesonide) inhalation aerosol
  • ANDEXXA<sup>®</sup> (coagulation factor Xa (recombinant), inactivated-zhzo) Lyophilized powder for solution for intravenous injection
  • BEVESPI AEROSPHERE<sup>®</sup> (glycopyrrolate and formoterol fumarate) inhalation aerosol
  • BREZTRI AEROSPHERE<sup>®</sup> (budesonide, glycopyrrolate, and formoterol fumarate) inhalation aerosol
  • BRILINTA<sup>®</sup> (ticagrelor) Tablets
  • BYDUREON BCise<sup>®</sup> (exenatide extended-release) injectable suspension
  • BYETTA<sup>®</sup> (exenatide) Injection
  • CALQUENCE<sup>®</sup> (acalabrutinib) Tablets
  • CRESTOR<sup>®</sup> (rosuvastatin calcium) Tablets
  • DALIRESP<sup>®</sup> (roflumilast) Tablets
  • DATROWAY<sup>®</sup> (datopotamab deruxtecan-dlnk)
  • DATROWAY<sup>®</sup> (datopotamab deruxtecan-dlnk)
  • ENHERTU<sup>®</sup> (fam-trastuzumab deruxtecan-nxki)
  • ENHERTU<sup>®</sup> (fam-trastuzumab deruxtecan-nxki)
  • FARXIGA<sup>®</sup> (dapagliflozin) Tablets
  • FASENRA<sup>®</sup> (benralizumab) injection, for subcutaneous use
  • FASLODEX<sup>®</sup> (fulvestrant) injection, for intramuscular use
  • FLUMIST<sup>®</sup> QUADRIVALENT (Influenza Vaccine Live, Intranasal)
  • IMFINZI<sup>®</sup> (durvalumab) injection, for intravenous use
  • IMJUDO (tremelimumab)
  • IRESSA<sup>®</sup> (gefitinib) Tablets
  • KANUMA<sup>®</sup> (sebelipase alfa) injection, for intravenous use
  • KOMBIGLYZE<sup>®</sup> XR (saxagliptin and metformin HCl extended-release) Tablets
  • KOSELUGO<sup>®</sup> (selumetinib) capsules, for oral use
  • LOKELMA<sup>®</sup> (sodium zirconium cyclosilicate) for Oral Suspension
  • LOKELMA<sup>®</sup> (sodium zirconium cyclosilicate) for Oral Suspension Spanish
  • LYNPARZA<sup>®</sup> (olaparib) Tablets
  • NEXIUM<sup>®</sup> (esomeprazole magnesium) for delayed-release oral suspension and delayed-release capsules
  • NEXIUM<sup>®</sup> I.V. (esomeprazole sodium) for injection, for intravenous use
  • NEXIUM<sup>®</sup> I.V. (esomeprazole sodium) for injection, for intravenous use
  • ONGLYZA<sup>®</sup> (saxagliptin) Tablets
  • PULMICORT RESPULES<sup>®</sup> (budesonide inhalation suspension)
  • QTERN<sup>®</sup> (dapagliflozin and saxagliptin) Tablets
  • SAPHNELO<sup>®</sup> (anifrolumab-fnia) Injection
  • SEROQUEL XR<sup>®</sup> (quetiapine) Extended-Release Tablets
  • SEROQUEL<sup>®</sup> (quetiapine fumarate) Tablets
  • SOLIRIS<sup>®</sup> (eculizumab) injection, for intravenous use
  • STRENSIQ<sup>®</sup> (asfotase alfa) injection, for subcutaneous use
  • SYMBICORT<sup>®</sup> (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
  • SYMBICORT<sup>®</sup> Spanish
  • SYMLIN<sup>®</sup> (pramlintide acetate) Injection
  • TAGRISSO<sup>®</sup> (osimertinib) Tablets
  • TAGRISSO<sup>®</sup> Japanese
  • TAGRISSO<sup>®</sup> Korean
  • TAGRISSO<sup>®</sup> Spanish
  • TAGRISSO<sup>®</sup> Mandarin
  • TAGRISSO<sup>®</sup> Tagalog
  • TAGRISSO<sup>®</sup> Vietnamese
  • TEZSPIRE<sup>®</sup> (tezepelumab-ekko) Injection, for subcutaneous use
  • TRUQAP (capivasertib)
  • ULTOMIRIS<sup>®</sup> (ravulizumab-cwvz) injection, for intravenous use
  • VOYDEYA<sup>™</sup> (danicopan) tablets, for oral use
  • VOYDEYA<sup>™</sup> (danicopan) tablets, for oral use
  • WAINUA<sup>™</sup> (eplontersen)
  • XIGDUO<sup>®</sup> XR (dapagliflozin and metformin HCI extended-release) Tablets

Request a field medical follow-up

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice